Fig. 5. (A, B) The expression levels of dorsal DRP1 and NR2B were measured after various treatments in remifentanil-induced hyperalgesia rats. (A) Expression levels of NR2B and DRP1 in groups after various treatments. (B) The fold change in the density of NR2B and DRP1 (mean ± standard deviation, n = 6). C: group control, R: group remifentanil, MM: group mismatch oligodeoxynucleotides to dynamin-related protein 1, AS: group antisense oligodeoxynucleotides against dynamin-related protein 1. *P < 0.05 compared with the group control. **P < 0.01 compared with the group control. #P < 0.05 compared with the group AS.
© Korean J Pain
